Form 8-K - Current report:
SEC Accession No. 0001827506-24-000078
Filing Date
2024-09-05
Accepted
2024-09-05 16:19:25
Documents
57
Period of Report
2024-09-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K trml-20240905.htm   iXBRL 8-K 28647
2 EX-99.1 tourmalinecorporateoverv.htm EX-99.1 63093
6 tourmalinecorporateoverv001.jpg GRAPHIC 41230
7 tourmalinecorporateoverv002.jpg GRAPHIC 281070
8 tourmalinecorporateoverv003.jpg GRAPHIC 86928
9 tourmalinecorporateoverv004.jpg GRAPHIC 128761
10 tourmalinecorporateoverv005.jpg GRAPHIC 143291
11 tourmalinecorporateoverv006.jpg GRAPHIC 179656
12 tourmalinecorporateoverv007.jpg GRAPHIC 130828
13 tourmalinecorporateoverv008.jpg GRAPHIC 173782
14 tourmalinecorporateoverv009.jpg GRAPHIC 116089
15 tourmalinecorporateoverv010.jpg GRAPHIC 19987
16 tourmalinecorporateoverv011.jpg GRAPHIC 160451
17 tourmalinecorporateoverv012.jpg GRAPHIC 125756
18 tourmalinecorporateoverv013.jpg GRAPHIC 177033
19 tourmalinecorporateoverv014.jpg GRAPHIC 153249
20 tourmalinecorporateoverv015.jpg GRAPHIC 128454
21 tourmalinecorporateoverv016.jpg GRAPHIC 135252
22 tourmalinecorporateoverv017.jpg GRAPHIC 201603
23 tourmalinecorporateoverv018.jpg GRAPHIC 164188
24 tourmalinecorporateoverv019.jpg GRAPHIC 115899
25 tourmalinecorporateoverv020.jpg GRAPHIC 136202
26 tourmalinecorporateoverv021.jpg GRAPHIC 28389
27 tourmalinecorporateoverv022.jpg GRAPHIC 139805
28 tourmalinecorporateoverv023.jpg GRAPHIC 108810
29 tourmalinecorporateoverv024.jpg GRAPHIC 140885
30 tourmalinecorporateoverv025.jpg GRAPHIC 155300
31 tourmalinecorporateoverv026.jpg GRAPHIC 133042
32 tourmalinecorporateoverv027.jpg GRAPHIC 172737
33 tourmalinecorporateoverv028.jpg GRAPHIC 142980
34 tourmalinecorporateoverv029.jpg GRAPHIC 116580
35 tourmalinecorporateoverv030.jpg GRAPHIC 175388
36 tourmalinecorporateoverv031.jpg GRAPHIC 133134
37 tourmalinecorporateoverv032.jpg GRAPHIC 140323
38 tourmalinecorporateoverv033.jpg GRAPHIC 144863
39 tourmalinecorporateoverv034.jpg GRAPHIC 114699
40 tourmalinecorporateoverv035.jpg GRAPHIC 154362
41 tourmalinecorporateoverv036.jpg GRAPHIC 120279
42 tourmalinecorporateoverv037.jpg GRAPHIC 186014
43 tourmalinecorporateoverv038.jpg GRAPHIC 140464
44 tourmalinecorporateoverv039.jpg GRAPHIC 123848
45 tourmalinecorporateoverv040.jpg GRAPHIC 172240
46 tourmalinecorporateoverv041.jpg GRAPHIC 123677
47 tourmalinecorporateoverv042.jpg GRAPHIC 142304
48 tourmalinecorporateoverv043.jpg GRAPHIC 29525
  Complete submission text file 0001827506-24-000078.txt   8295568

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trml-20240905.xsd EX-101.SCH 1919
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trml-20240905_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trml-20240905_pre.xml EX-101.PRE 13593
59 EXTRACTED XBRL INSTANCE DOCUMENT trml-20240905_htm.xml XML 2915
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40384 | Film No.: 241281638
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)